Trends in cause-specific mortality in oxygen-dependent chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 8, 2011, Pages 1032-1036

  Ekström, Magnus P ^a,c   Wagner, Philippe ^b   Ström, Kerstin E ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c BLEKINGE HOSPITAL   (Sweden)

Author keywords

Comorbidity; COPD; Mortality; Oxygen inhalation therapy; Survival

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIGESTIVE SYSTEM DISEASE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; LONG TERM OXYGEN THERAPY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OXYGEN THERAPY; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RESPIRATORY TRACT DISEASE; SMOKING; STANDARDIZED MORTALITY RATIO; SWEDEN; TREATMENT DURATION; TREND STUDY;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMANS; HYPERBARIC OXYGENATION; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SWEDEN;

EID: 79954617458     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201010-1704OC     Document Type: Article

References (28)

1. Crockett AJ, Cranston JM, Moss JR, Alpers JH. Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Intern Med J 2001;31:448-454.
2. Ekström M, Franklin KA, Ström KE. Increased relative mortality in women with severe oxygen-dependent COPD. Chest 2010;137:31-36.
3. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391-398.
4. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: Report of the Medical Research Council Working Party. Lancet 1981;1:681-686.
5. Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10:2794-2800. (Pubitemid 28052790)
6. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008;32:962-969.
7. Franklin KA, Gustafson T, Ranstam J, Ström K. Survival and future need of long-term oxygen therapy for chronic obstructive pulmonary disease-gender differences. Respir Med 2007;101:1506-1511. (Pubitemid 46832229)
8. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring e Jr, She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006;16:63-70. (Pubitemid 41783891)
9. Curkendall SM, Lanes S, de Luise C, Stang MR, Jones JK, She D, Goehring e Jr. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur J Epidemiol 2006;21:803-813. (Pubitemid 44885203)
10. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655. (Pubitemid 13149996)
11. World Health Organization. Manual of the international classification of diseases, injuries and causes of death, 9th revision, Vol. 1. Geneva, Switzerland: World Health Organization; 1978.
12. World Health Organization. Manual of the international statistical classification of diseases and health related problems, 10th revision, Vol. 1. Geneva, Switzerland: World Health Organization; 1992.
13. Cox DR. Regression models and life-tables. J Am Stat Assoc 1972;34:187-220.
14. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
15. Rathouz PJ. Identifiability assumptions for missing covariate data in failure time regression models. Biostatistics 2007;8:345-356. (Pubitemid 46569595)
16. Frome EL, Checkoway H. Epidemiologic programs for computers and calculators: use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol 1985;121:309-323. (Pubitemid 15158542)
17. Zielinski J, MacNee W, Wedzicha J, Ambrosino N, Braghiroli A, Dolensky J, Howard P, Gorzelak K, Lahdensuo A, Ström K, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis 1997;52:43-47. (Pubitemid 27232210)
18. Ström K, Boe J. A national register for long-term oxygen therapy in chronic hypoxia: preliminary results. Eur Respir J 1988;1:952-958. (Pubitemid 19015311)
19. Johansson L. Mortality bridge coding ICD9/ICD10: preliminary results from a Statistics Sweden study (WHO/GPE/ICD/C/00.66). In: Meeting of heads of WHO collaborating centres for the classification of diseases, October 15-21, Rio de Janeiro, Brazil, 2000. Publication no. WHO/GPE/ICD/C/00.71. Geneva, Switzerland: World Health Organization; 2000. Available from: http://www.who.int/ classifications/network/en/report2000.pdf.
20. Statistics Sweden. Living conditions. Report no. 105. Health related habits of life 1980-2002. Stockholm, Sweden: Statistics Sweden; 2004.
21. de Torres JP, Campo A, Casanova C, Aguirre-Jaime A, Zulueta J. Gender and chronic obstructive pulmonary disease in high-risk smokers. Respiration 2006;73:306-310. (Pubitemid 43725787)
22. Xu X, Li B, Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994;7:477-483. (Pubitemid 24099008)
23. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J 2003;21:1017-1023. (Pubitemid 36675620)
24. Gan WQ, Man SFP, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res 2006;7:52.
25. Statistics Sweden. Causes of death 2008. Stockholm, Sweden: Statistics Sweden; 28 April 2010 [accessed 13 December 2010]. Available from: http://www.socialstyrelsen. se/publikationer2010/2010-4-31.
26. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005;128:2640-2646. (Pubitemid 41507622)
27. Marti S, Munoz X, Rios J, Morell F, Ferrer J. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 2006;27:689-696. (Pubitemid 44914190)
28. Bjorck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009;30:1046-1056.